切换至 "中华医学电子期刊资源库"
高级检索
中华妇幼临床医学杂志(电子版)

中华妇幼临床医学杂志(电子版) ›› 2013, Vol. 09 ›› Issue (06) : 735 -739. doi: 10.3877/cma.j.issn.1673-5250.2013.06.004

所属专题： 专题评论； 文献；

论著

血液净化治疗小儿重症肺炎的疗效评价
张利娟1, 王峥1,*,*()   
  1. 1. 610041　成都，四川大学华西第二医院
  • 收稿日期:2013-06-30 修回日期:2013-10-30 出版日期:2013-12-01
  • 通信作者: 王峥

Evaluation Clinical Effect of Blood Purification in Pediatric Severe Pneumonia

Li-juan ZHANG1, Zhang WANG1()   

  1. 1. Department of Pediatric, West China Second University Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
  • Received:2013-06-30 Revised:2013-10-30 Published:2013-12-01
  • Corresponding author: Zhang WANG
  • About author:
    (Corresponding author : WANG Zheng,Email : )
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

张利娟, 王峥. 血液净化治疗小儿重症肺炎的疗效评价[J]. 中华妇幼临床医学杂志(电子版), 2013, 09(06): 735-739.

Li-juan ZHANG, Zhang WANG. Evaluation Clinical Effect of Blood Purification in Pediatric Severe Pneumonia[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2013, 09(06): 735-739.

目的

评价血液净化技术用于治疗儿童重症肺炎的临床疗效。

方法

回顾性分析2009年1月至2013年2月在四川大学华西第二医院接受住院治疗的51例重症肺炎患儿的临床病历资料，按照是否接受血液净化治疗将其分为实验组(n = 27)与对照组(n = 24)（本研究遵循的程序符合本院人体试验委员会制定的伦理学标准，得到该委员会批准，分组征得受试对象监护人的知情同意，并与其签署临床研究知情同意书）。两组患儿的年龄，性别，呼吸机辅助通气率及治疗前小儿危重症评分(PCIS)，体温，呼吸频率，心率，白细胞(WBC)计数，C-反应蛋白(CRP)，血糖，丙氨酸转氨酶(ALT)，血尿素氮(BUN)，血Na+异常率，血K+异常率，动脉血PH值，HCO3-及血气分析结果等比较，差异均无统计学意义(P>0.05)。采用统计学方法分析评价两组患儿的死亡率，平均住院日及治疗前及治疗后5 d的体温、呼吸频率、心率及各项实验室检查指标。

结果

实验组患儿的死亡率显著低于对照组[40. 7%(11/27) vs. 70.8%(17/24)]，差异有统计学意义(P = 0.031)。治疗5 d后，实验组患儿体温、心率均明显下降，疗效优于对照组[(37. 13 ± 0. 71)℃ vs. (37. 94±1. 34)℃，(121. 63±21.16)次/min vs. (151. 11±29. 31)次/min]，且差异有统计学意义(P<0.05);实验组血清Na+异常率下降[由64%(16/27)下降至20% (5/27)]较对照组[无改变，均为53.3%(8/24)]明显，差异有统计学意义(P=0.029)；实验组血清K+异常率下降[由48% (12/27)下降至28%(7/27)]较对照组[由40%(6/24)上升为60%(9/24)]明显，差异有统计学意义(P = 0. 046)；实验组患儿的CRP水平较治疗前明显下降，差异有统计学意义(P<0. 05)；对照组动脉血PH值较治疗前明显上升，差异有统计学意义(P<0. 05)。两组患儿治疗前和治疗5 d后WBC计数、血糖水平、ALT和动脉血HCO3-水平、动脉血二氧化碳分压()改变比较，差异均无统计学意义(P>0.05)。

结论

血液净化治疗儿童重症肺炎疗效较好，但是否值得临床推广应用，尚需多中心、大样本随机对照研究进一步证实。

关键词: 血液净化, 重症肺炎, 儿童
Objective

To evaluate clinical effect of blood purification in treatment of children with severe pneumonia.

Methods

This was a retrospective study with institutional ethics approval and written parents of each participating children consent. From January 2009 to February 2013,a total of 51 children with severe pneumonia admitted to West China Second University Hospital, Sichuan University were recruited. According to whether being given blood purification, they were divided into treatment group(n = 27) and control group(n= 24). There had no significance difference between two groups among sex, age, pediatric critical illness score (PCIS) before treatment, rate of mechanical ventilation, and body temperature,breathing rate,heart rate,white blood cell (WBC) count, C-reactive protein (CRP),blood glucose,alanine transarninase (ALT) , Na+ and K+ in blood,and result of blood gas analysis before treatment (P>0. 05). Mortality rate,hospital days, clinical situations and laboratory data before and after treatment for 5 d were analyzed by statistics.

Results

Mortality rate in treatment group was significantly lower than that in control group [40. 7% (11/27) vs. 70. 8% (17/24) , P<0. 05]. After 5 d treatment, temperature and heart rate in treatment group were significantly lower than those before treatment [ (37. 13℃±0. 71) ℃ vs. (37. 94±1. 34)℃, (121. 63±21. 16)/min vs. (151.11±29. 31)/min; P<0. 05], which were lower than those in control group(P<0. 05). There had significance difference between two groups among serum Na+ and K+ abnormal rates(P = 0. 029 ,0. 046),in treatment group that Na+ and K+ abnormal rate which decreased after 5 d treatment fell to 20%(5/27) from 64%(16/27) and fell to 28%(7/ 27)from 48(12/27), respectively; but no change in control group [53. 3%(8/24)] and while rised from 40% (6/24) to 60%(9/24) ,respectively. There had significance difference of CRP level in treatment group after 5 d treatment than that before treatment (P<0. 05) ; the PH value of arterial blood was rising after 5 d treatment than that before treatment in control group (P< 0. 05). There was no significance difference between two groups among WBC count, blood glucose,ALT, creatinine,blood urea nitrogen (BUN) and arterial carbon dioxide tension () before treatment and after 5 d treatment (P>0. 05).

Conclusions

Blood purification in treatment of pediatric severe pneumonia can get better results. More prospective studies are necessary to determine the effectiveness of blood purification in pediatric severe pneumonia.

Key words: blood purification, severe pneumonia, child
表1 实验组患儿血液净化治疗方式[±s(rang)]
Table 1 Treatment strategies of blood purification in treatment group [±s (rang)]
治疗方式 n 平均次数(次） 总时间(h)
CRRT 19 3. 16±1. 77(1. 0~7. 0) 24. 18±14. 34(8. 0~56. 0)
CRRT+HP 3 1 HP+[2. 67±1. 53](1. 0~4. 0)CRRT 2. 0 (HP) + [22. 00±12. 17](8. 0～30. 0)(CRRT)
HP 2 1. 50 ± 0. 71(1. 0～2. 0) 3. 00 ± 1. 41(2. 0～4. 0)
PE 3 1. 67±0. 58(1. 0~2. 0) 2. 50±1. 32(1. 5~4. 0)
表2 两组患儿一般情况临床资料比较[n(%)]
Table 1 Comparison of general clinical data between two groups [n(%)]
组别 n 性别 年龄（岁） 呼吸机辅助通气率
男性 女性 ≤1 >1
实验组 27 16(59. 3) 11(40. 7) 4(14. 8) 23(85. 2) 14(51. 9)
对照组 24 17(70. 8) 7(29. 2) 9(37. 5) 15(62. 5) 13(54. 2)
χ2 ? 0. 745 3. 443 0. 027
P ? 0. 388 0. 640 0. 869
表3 两组患儿治疗前PCIS评分比较(±s)
Table 2 Comparison of PCIS scores before treatment between two groups(±s)
组别 n PCIS评分(分） t P
实验组 27 79. 41 ± 9. 48 1. 098 0. 277
对照组 24 81. 92±6. 31 ? ?
表4 两组患儿病死率比较[n(%)]
Table 4 Comparison of mortality between two groups[n(%)]
? n 病死率 χ2 P
实验组 27 11(40. 7) 4. 647 0. 031
对照组 24 17(70.8) ? ?
表5 两组患儿治疗前和治疗5 d后生命体征组内与组间比较（实际受试例数）
Table 5 Comparison of physical signs before and after treatment 5 days within and between two groups (actual cases)
组别 n 体温(℃) 呼吸频率(次/min) 心率(次/min)
治疗前 治疗5 d后 治疗前 治疗5 d后 治疗前 治疗后
实验组 27 37. 94±1. 34(27) 37. 13±0. 71(27)b 41. 81±14. 10(27) 36. 11±9. 60(27)b 151.11±29. 31(27) 121. 63±21. 16(27)b
对照组 24 37. 74±1. 13(20) 37. 86 ± 0. 98(20)a 47. 90± 8.56(20) 38. 4±11. 8(20)a 160. 25 ± 33. 99(20) 137. 50 ± 25. 83(20)a
t ? 0. 543 —2. 965 -2. 145 —0. 732 —0. 987 —2. 313
P ? 0. 59 0. 005 0. 037 0. 468 0. 329 0. 025
表6 两组患儿治疗前及治疗5 d后实验室监测指标组内与组间比较（实际受试例数）
Table 6 Comparison of laboratory indexes before and after treatment 5 days within and between two groups (actual cases)
组别 WBC(109/L) CRP(mg/L) 血糖(?mmoL?/L)
治疗前 治疗后 治疗前 治疗后 治疗前 治疗后
实验组 13. 88±10. 09(27) 13. 37±7. 59(27)a 103. 10±122. 88(20) 22. 75±31. 08(20)b 9. 00 ± 4. 99(20) 7. 21±2. 68(20)a
对照组 10. 42±5. 58(14) 11. 28 ± 4. 84(14)d 50. 27± 67. 70(11) 30. 27±52. 11(11)d 6. 45±3. 03(12) 5. 67 ± 2. 34(12)d
t 1. 413 0. 949 1. 314 -0. 506 1. 597 1. 649
P 0. 166 0. 349 0. 199 0. 617 0. 121 0. 110
组别 Cr(?μmol?/L) BUN(?mmol?/L) ALT(U/L)
治疗前 治疗后 治疗前 治疗后 治疗前 治疗后
实验组 89. 33±92. 99(20) 46. 25 ± 37. 86(20)c 10. 71±10. 14(20) 7. 08 ± 4. 81(20)a 249. 59 ± 394. 34(22) 173. 27±422. 52(22)a
对照组 39. 11 ± 28. 43(9)d 42. 56 ± 37. 31(9)d 5. 69 ± 4. 35(9) 6. 17±5. 39(9)d 173. 00 ± 348. 06(8) 176. 50±339. 86(8)d
t 2. 198 0. 240 1. 862 0. 457 0. 484 -0. 019
P 0. 037 0. 809 0. 074 0. 651 0. 632 0. 985
组别 PH值 HCO3- (?mmol?/L) (?kPa?)
治疗前 治疗后 治疗前 治疗后 治疗前 治疗后
实验组 7. 36±0. 17(18) 7. 39±0. 11(18)a 23. 09±10. 29(18) 26. 08±8. 93(18)a 5. 29±2. 19(18) 5. 70±2. 62(18)a
对照组 7. 36±0. 08(14) 7. 45±0. 08(14)e 22. 86± 7. 71(14) 29. 04±9. 57(14)d 5. 31±1. 56(14) 5. 56±1. 87(14)d
t 0. 084 -1. 559 0. 068 -0. 901 -0. 027 0. 172
P 0. 934 0. 130 0. 946 0. 375 0. 530 0. 970
表7 两组患儿治疗前和治疗5 d后血电解质水平异常率比较[n'/n(％)]
Table 7 Comparison of abnormal rates of blood electrolyte level before and after treatment 5 days between two groups [n'/n(%)]
组别 n Na+ K+ ?Cl?-
治疗前 治疗后 治疗前 治疗后 治疗前 治疗后
实验组 27 16/25(64. 0) 5/25(20. 0) 12/25(448. 0) 7/25(28. 0) 12/24(50.0) 6/24(25.0)
对照组 24 8/15(53. 3) 8/15(53. 3) 6/15(40. 0) 9/15(60. 0) 3/13(23. 1) 5/13(38. 5)
χ2 ? 0. 444 4. 748 0. 242 4. 000 2. 536 0. 731
P ? 0. 505 0. 029 0. 622 0. 046 0. 111 0. 392
1
Rudan I, Boschi-Pinto C, Biloglav Z, et al. Epidemiology and etiology of childhood pneumonia [J]. Bull World Health Organ, 2008, 86(5):408-416.
2
Yang XQ, Hang Y, Shu C, et al. Analysis of treatment effectiveness of 272 cases of severe community- acquired pneumonia in children[J]. J Chongqing Med Univ, 2010,35(10) : 1580-1583.
3
Geng Y, Cheng XN. Clinical process analysis and treatment of severe pneumonia in infants [J]. J Appl Clin Pediatr,2005,20 (10) : 948-950.
4
The Subspecialty Group of pneumatology, Pediatric Society, Chinese Medical Association. Guidelines for the management of community-acquired pneumonia (CAP) in pediatric patients (trial) (part I)[J]. Chin J Pediatr, 2007,45 (02) : 83-90.
5
The Subspecialty Group of pneumatology, Pediatric Society, Chinese Medical Association. Guidelines for the management of community-acquired pneumonia (CAP) in pediatric patients(trial) (part Ⅱ) [J]. Chin J Pediatr, 2007,45(03) : 223-230.
6
Li QB, Feng J H, Cheng SJ. Clnical observation of severe pneumonia treated with edaravone and continuous veno-venous hemofiltration[J]. Chin J Crit Care Med, 2011,31(5): 457-458.
7
Reng XX, Song GW. Pediatric risk of mortality Ⅲ score and pediatric critical illness score[J]. J Appl Clin Pediatr,2006,21(6): 382-384.
8
Alberti C, Brun-Buisson C, Chevret S, et al. Systemic inflammatory response and progression to severe sepsis in critically ill infected patients[J]. Am J Respir Crit Care Med, 2005,171(5): 461-468.
9
Briassoulis G, Venkataraman S, Thompson A. Cytokines and metabolic patterns in pediatric patients with critical illness[J]. Clin Dev Immunol, 2010:354-347.
10
Carcillo J A. Pediatric septic shock and multiple organ failure[J]. Crit Care Clin, 2003,19(3) :413-440.
11
Gu X, Jing FG, Fu EQ, et al. Effect of cytokines in pathogenesis of acute respiratory distress syndrome [J]. Prog Modern Biomed, 2007,7 (9): 1383-1386.
12
Therapies R. Continuous renal replacement therapies (CRRT) [J]. Blood Purif, 2002,20:305-323.
13
Ronco C, Tetta C, Mariano F, et al. Interpreting the mechanisms of continuous renal replacement therapy in sepsis : The peak concentration hypothesis[J]. Artif Organs, 2003,27(9) : 792-801.
14
Honore PM, Jamez J, Wauthier M, et al. Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock[J]. Crit Care Med, 2000, 28(11):3581-3587.
[1] 张璇, 马宇童, 苗玉倩, 张云, 吴士文, 党晓楚, 陈颖颖, 钟兆明, 王雪娟, 胡淼, 孙岩峰, 马秀珠, 吕发勤, 寇海燕. 超声对Duchenne肌营养不良儿童膈肌功能的评价[J]. 中华医学超声杂志（电子版）, 2023, 20(10): 1068-1073.
[2] 张宝富, 俞劲, 叶菁菁, 俞建根, 马晓辉, 刘喜旺. 先天性原发隔异位型肺静脉异位引流的超声心动图诊断[J]. 中华医学超声杂志（电子版）, 2023, 20(10): 1074-1080.
[3] 韩丹, 王婷, 肖欢, 朱丽容, 陈镜宇, 唐毅. 超声造影与增强CT对儿童肝脏良恶性病变诊断价值的对比分析[J]. 中华医学超声杂志（电子版）, 2023, 20(09): 939-944.
[4] 刘婷婷, 林妍冰, 汪珊, 陈幕荣, 唐子鉴, 代东伶, 夏焙. 超声衰减参数成像评价儿童代谢相关脂肪性肝病的价值[J]. 中华医学超声杂志（电子版）, 2023, 20(08): 787-794.
[5] 周钰菡, 肖欢, 唐毅, 杨春江, 周娟, 朱丽容, 徐娟, 牟芳婷. 超声对儿童髋关节暂时性滑膜炎的诊断价值[J]. 中华医学超声杂志（电子版）, 2023, 20(08): 795-800.
[6] 米洁, 陈晨, 李佳玲, 裴海娜, 张恒博, 李飞, 李东杰. 儿童头面部外伤特点分析[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 511-515.
[7] 中华医学会烧伤外科学分会小儿烧伤学组. 儿童烧伤早期休克液体复苏专家共识(2023版)[J]. 中华损伤与修复杂志(电子版), 2023, 18(05): 371-376.
[8] 王蕾, 王少华, 牛海珍, 尹腾飞. 儿童腹股沟疝围手术期风险预警干预[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 768-772.
[9] 李芳, 许瑞, 李洋洋, 石秀全. 循证医学理念在儿童腹股沟疝患者中的应用[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 782-786.
[10] 彭永辉, 张文杰, 李炳根, 聂向阳, 吴凯, 杨六成. 单孔双针疝囊高位结扎术在儿童巨大腹股沟疝的临床应用[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(05): 566-569.
[11] 周顺, 赵素侠, 时静静, 吴双双, 吴圆圆, 李金山. 丙泊酚-舒芬太尼复合七氟烷吸入对小儿腹腔镜疝囊高位结扎术的麻醉效果及安全性[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(05): 603-607.
[12] 吕垒, 冯啸, 何凯明, 曾凯宁, 杨卿, 吕海金, 易慧敏, 易述红, 杨扬, 傅斌生. 改良金氏评分在儿童肝豆状核变性急性肝衰竭肝移植手术时机评估中价值并文献复习[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 661-668.
[13] 卓少宏, 林秀玲, 周翠梅, 熊卫莲, 马兴灶. CD64指数、SAA/CRP、PCT联合检测在小儿消化道感染性疾病鉴别诊断中的应用[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 505-509.
[14] 刘笑笑, 张小杉, 刘群, 马岚, 段莎莎, 施依璐, 张敏洁, 王雅晳. 中国学龄前儿童先天性心脏病流行病学研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1021-1024.
[15] 李静, 张玲玲, 邢伟. 兴趣诱导理念用于小儿手术麻醉诱导前的价值及其对家属满意度的影响[J]. 中华临床医师杂志(电子版), 2023, 17(07): 812-817.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号